Company Description:
IRC is a phase I-IV clinical research organization that was established in 1999. Our objective is to provide the highest quality clinical trial services for the drug development process in the Biotechnology, Medical Device and Pharmaceutical industries. Since our establishment, we have been able to develop numerous clients within the Pharmaceutical and Biotechnolgy industries that continuously provide our organization with various study opportunities.
Due to the current market, our organization is seeking working capital to expand our CRO operations in North America and South America as well as further fund our study recruitment efforts.
Currently, we are seeking an investment amount of $500,000 to cover operational expenses and marketing expenses for our expansion project.
|
Number of Employees:
|
Stage of Business:
|
|